CS MEDICA A/S: CEO Lone Henriksen buys shares in the Company

22 June 2022 - 08:00

CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CEO of the Company, Lone Henriksen, has today acquired 6 328 shares in CS MEDICA at a price of 5,80, amounting to a total value of 36 702,4 DKK including commission.

CEO of CS MEDICA, Lone Henriksen, has purchased 6 328 shares in the open market at a price of DKK 5,80 per share, corresponding to a total purchase of 36 702,4 DKK including commission. The transaction has been disclosed in the Danish financial supervisory register. Following the transaction, Lone owns 4 019 781 CS MEDICA shares.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: [email protected]

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA

Provided by: Cision
Spotlight Stock Market (Sweden)
CS Medica A/S
CS Medica fully owns two Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxapharma A/S is a product distributor in the Nordic Region....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More